Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL358037

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
COc1ccc(COc2cc(OC)c(OC)c(OC)c2)cc1OCC(O)CO

Basic Information

ChEMBL ID CHEMBL358037
Phase Preclinical
Structure Type MOL
InChI Key MGYHEJDITQIJLQ-UHFFFAOYSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names

Molecular Properties

394.4
MW (Da)
2.03
ALogP
8
HBA
2
HBD
95.8
PSA (Ų)
0.60
QED
0
Ro5 Violations
11
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C20H26O8
MW 394.42
Aromatic Rings 2
Heavy Atoms 28
NP-Likeness 0.17

Activity Summary

IC50 1 meas. best 4.05

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
K562
CHEMBL385
IC50 4.05 4.05 90000.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
K562 IC50 = 90000.0 nM 4.05 Concentration required for 50% inhibition of K562 human chronic myelogenous leuk... 11140732

Literature References

PubMed DOI Target Context # Activities
11140732 10.1016/s0960-894x(00)00596-5 K562 1
15658859 10.1021/jm049444m Tubulin beta-1 chain 1

Data from ChEMBL 36 via Core Engine